Iconic Labs PLC Conversion of Notes -- Replacement (8063M)
September 18 2023 - 1:27PM
UK Regulatory
TIDMICON
RNS Number : 8063M
Iconic Labs PLC
18 September 2023
Iconic Labs PLC
("Iconic" or the "Company")
Conversion of Notes and Allotment of Shares
The following amendments have been made to the "Conversion of
Notes and Allotment of Shares" announcement released on 18
September 2023 at 07:37a.m. under RNS No. 7444M.
The figure for the number of shares for which application is
being made referenced in the third paragraph should be 236,406 new
Ordinary Shares and the two figures for the total issued share
capital and total voting rights in the fourth paragraph, should
both be 5,239,681. All other details remain unchanged. The full
amended text is shown below.
Iconic Labs PLC (LSE:ICON), announces that it has received a
valid Conversion Notice from the European High Growth Opportunities
Securitization Fund.
The Conversion Notice was dated 14 September 2023 and provides
for 30 Convertible Notes to be converted into 236,406 ordinary
shares of GBP0.1 in the Company ("Ordinary Shares") at a conversion
price of GBP0.1269 at the aggregate principal amount of
GBP30,000.
Application is being made for 236,406 new Ordinary Shares to be
admitted to trading on the Main Market of the London Stock Exchange
which is expected to be on or around 22 September 2023. These
shares rank pari passu with the existing Ordinary Shares of the
Company.
Following the issue of these shares, the Company's issued
ordinary share capital shall consist of 5,239,681 Ordinary Shares.
The figure of 5,239,681 represents the total voting rights in the
Company and should be used by shareholders as the denominator for
the calculation by which they can determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the Financial Conduct Authority's Disclosure Guidance
& Transparency Rules.
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it
forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with
the Company's obligations under Article 17 of MAR.
For any further information or enquiries please contact:
ir@iconiclabs.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
CONGPUWGBUPWGWR
(END) Dow Jones Newswires
September 18, 2023 13:27 ET (17:27 GMT)
Iconic Labs (LSE:ICON)
Historical Stock Chart
From Jul 2024 to Aug 2024
Iconic Labs (LSE:ICON)
Historical Stock Chart
From Aug 2023 to Aug 2024